SB 205952, a novel semisynthetic monic acid analog with at least two modes of action.

The biological properties of SB 205952, a nitrofuryl oxazole derivative of monic acid, differ from those of the closely related antibacterial agent mupirocin. Compared with mupirocin, SB 205952 has increased antimicrobial potency, an extended spectrum including mupirocin-resistant staphylococci, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Wilson, J M, Oliva, B, Cassels, R, O'Hanlon, P J, Chopra, I
Format: Artigo
Language:Inglês
Published: 1995
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC162858/
https://ncbi.nlm.nih.gov/pubmed/8540693
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items